Healthcare
Evotec SE
EVOPrice is delayed.
About Evotec SE
Evotec discovers and develops pharmaceutical drugs for diseases including cancer, diabetes, heart failure, and autoimmune conditions. The company operates research laboratories that work on drug development projects, often in partnership with other pharmaceutical companies, universities, and medical centers like Harvard and Johns Hopkins. They also offer drug discovery services to other companies that want to develop their own medicines. Evotec is headquartered in Hamburg, Germany, and was founded in 1993.
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore